Want to see BCLI full AI Analyst Report?
Brainstorm Cell Therapeutics (BCLI) Q2 2024 Earnings Report
BCLI Q2 2024 EPS Results
- Actual EPS
- $0.60
- Consensus EPS
- -$0.53
- Beat/Miss
- Beat by +$1.13
- One Year Ago EPS
- -$1.95
BCLI Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/14/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 14, 2024
BCLI Upcoming Earnings
Brainstorm Cell Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
BCLI Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
BCLI Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.18- | -0.19 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | ―-0.35 | -0.34 | -2.94% (-0.01) | |
| May 15, 2026 | 2026 (Q1) | ―-0.19 | -0.45 | 57.78% (+0.26) | |
| Mar 31, 2026 | 2025 (Q4) | -0.28-0.19 | -0.45 | 57.78% (+0.26) | |
| Nov 14, 2025 | 2025 (Q3) | -0.37-0.19 | -0.51 | 62.75% (+0.32) | |
| Aug 14, 2025 | 2025 (Q2) | -0.37-0.34 | 0.6 | -156.67% (-0.94) | |
| May 16, 2025 | 2025 (Q1) | ―-0.45 | -0.75 | 40.00% (+0.30) | |
| Mar 31, 2025 | 2024 (Q4) | -0.97-0.45 | -0.75 | 40.00% (+0.30) | |
| Nov 14, 2024 | 2024 (Q3) | -0.57-0.51 | -0.45 | -13.33% (-0.06) | |
| Aug 14, 2024 | 2024 (Q2) | -0.530.60 | -1.95 | 130.77% (+2.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
